The research study is anticipated to be finished in loss 2025.
发布者：BY CHRISTOPHER DUE KARLSSON，转转请注明出处：https://robotalks.cn/novo-nordisk-starts-phase-ii-trial-with-amycretin-in-t2d-and-obesity/
Novo Nordisk starts Phase II trial with amycretin in T2D and obesity
赞 (0)
关于作者
Delivery robots’ green credentials make them more attractive to consumers, finds study
上一篇
13 8 月, 2024 6:20 下午
Bavarian Nordic to test smallpox vaccine for children
下一篇
13 8 月, 2024 7:18 下午
相关推荐
-
CleanTech Lithium DLE moves to next stage
Examinations reveal CTL can generate battery-grade lithium carbonate .
-
Zyxel Networks, le soluzioni AI ready per i piccoli produttori
Negli ultimi anni, Zyxel Networks, società specializzata nella fornitura di soluzioni di rete sicure e basate sul cloud, ha trasformato gli impianti di produzione di tutto il mondo…
-
China’s solar sector blazes trail in commitment to renewables
Numerous rows of beaming panels bury swathes of scrubby sand at sundown in a remote north Chinese desert– as soon as the greatest solar ranch on the planet.
-
4 Reasons to Attend the 2024 Autonomous Mobile Robots & Logistics Conference
Allotment This On X: Create treasured insights into the most up-to-date advancements, handiest practices, and rising trends shaping the manner forward for logistics and warehousing at the Self reliant Mobile Robots & Logistics Convention. Whether you’re current to automation or ready to ramp up your initiatives, there are various lessons to point to you how
-
Zoom sees more sales from some of its biggest customers, and stock rises
Communications technology business likewise assisted for a far better present quarter, and a far better year …Read More
